Humana Inc vs Wheaton Precious Metals Corp — how do they compare? Humana Inc trades at $398.55 (market cap $47.81B), while Wheaton Precious Metals Corp trades at $105.92 (market cap $46.54B). The key difference: Humana Inc and Wheaton Precious Metals Corp are close in size by market cap, and Humana Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals.
| HUM | WPM | |
|---|---|---|
Market Cap | $47.81B | $46.54B |
Sector | Health | Basic Materials |
52-Week High | $409.42 | $165.72 |
52-Week Low | $163.67 | $91.00 |
Enterprise Value | $56.85B | $44.39B |
Dividend Yield | 0.89% | 0.75% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Wheaton Precious Metals (WPM) trades at $103.81, down 0.36% today, with a bearish technical signal and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.28 exceeding the $1.24 estimate. Revenue surged to $2.31 billion in 2025, driving a net income margin of 63.58%. Operating cash flow reached a record $1.90 billion, supporting a positive net cash flow of $335.43 million. Analyst consensus remains strongly bullish with an 80% buy rating and a $161.75 price target, indicating significant upside potential.
WPM presents a compelling investment case based on robust fundamentals and strong analyst support, though technical indicators suggest near-term caution. Key opportunities include sustained earnings growth, high profit margins, and a solid cash flow outlook. Risks involve exposure to precious metal price volatility, geopolitical tensions impacting mining operations, and potential valuation compression if silver prices remain subdued. The stock's current price offers an attractive entry point relative to analyst targets, but investors should monitor commodity market trends and quarterly performance closely.
Trailing returns across standard periods
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →